Investigation protocol: acromegaly and its investigation.
Duncan
E
E
Department of Endocrinology, Radcliffe Infirmary, Oxford, UK.
Wass
J A
JA
D000172:Acromegaly / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D015415:Biomarkers / Q000097:blood / Q000652:urine; D018491:Dopamine Agonists; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood / Q000652:urine; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008279:Magnetic Resonance Imaging; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications / Q000175:diagnosis; D013973:Thyrotropin-Releasing Hormone
D015415:Biomarkers; D018491:Dopamine Agonists; D018972:Insulin-Like Growth Factor Binding Protein 3; D013973:Thyrotropin-Releasing Hormone; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone